Literature DB >> 15220673

Clinical experience with probiotics in the elderly on total enteral nutrition.

Mario Del Piano1, Marco Ballarè, Franco Montino, Marco Orsello, Enrico Garello, Patrizio Ferrari, Cinzia Masini, Gian Paolo Strozzi, Filomena Sforza.   

Abstract

BACKGROUND: Recent data support that after 2 years of age, intestinal microflora remains relatively constant over time, except in elderly people, who harbor fewer bifidobacteria and a higher population of fungi and enterobacteria than young adults. Diet supplementation with probiotics may improve the nutritional status and reduce the impaired immunity associated with aging. The goal of this study was to establish the effect on bifidobacteria fecal counts, and some clinical parameters, of bifidobacteria supplementation to elderly patients in total parenteral nutrition.
METHODS: Thirteen patients (6 men and 7 women; mean age, 69 years; range, 65-76 years) affected by permanent vegetative status (PVS) and fed by total enteral nutrition (TEN) were studied. Bifidobacteria and clostridia were investigated by microbiologic and molecular biology methods in stool specimens collected twice at basal time (T-2 and T0) and after 12 and 15 days (T12 and T15, respectively). Seven patients with basal bifidobacteria counts less than 10 were supplemented with Bifidobacterium longum W 11 for 12 days. The remaining 6 patients were used as control subjects. For 1 month diarrhea and fever episodes, use of antibiotics, and nutritional status (BMI) were assessed.
RESULTS: In the 7 patients with bifidobacteria counts less than 10, the administration of B. longum W 11 resulted in a 1 log increase in 6 of 7 patients at T12. No statistically significant difference in episodes of fever or diarrhea, use of antibiotics, or BMI was observed between the treatment and control groups.
CONCLUSION: The administration of B. longum W11 in PVS patients fed by TEN is effective in increasing the population of bifidobacteria. Larger studies with longer follow-up could demonstrate the influence of these microbiologic changes in a clinical setting.

Entities:  

Mesh:

Year:  2004        PMID: 15220673     DOI: 10.1097/01.mcg.0000128937.32835.7c

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  2 in total

1.  Gut-targeted immunonutrition boosting natural killer cell activity using Saccharomyces boulardii lysates in immuno-compromised healthy elderly subjects.

Authors:  Yasuhiro Naito; Francesco Marotta; Makoto K Kantah; Nicola Zerbinati; Almagul Kushugulova; Zhaxybay Zhumadilov; Nicola Illuzzi; Chiara Sapienza; Hiroshi Takadanohara; Riyichi Kobayashi; Roberto Catanzaro
Journal:  Rejuvenation Res       Date:  2014-04-11       Impact factor: 4.663

2.  Isolation and identification of probiotic Lactobacillus from local dairy and evaluating their antagonistic effect on pathogens.

Authors:  Sahar Karami; Mohammad Roayaei; Hosna Hamzavi; Mahmoud Bahmani; Hassan Hassanzad-Azar; Mahmoodnia Leila; Mahmoud Rafieian-Kopaei
Journal:  Int J Pharm Investig       Date:  2017 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.